TABLE 3.
Post-discharge follow-up characteristics and odds of 30-day readmission after a hospitalization for heart failure
| Crude Odds Ratio (95% Confidence Interval) |
Adjusted Odds Ratioa (95% Confidence Interval) |
|
|---|---|---|
| Time to first contact | ||
| None within 30 days | Reference | Reference |
| 1 to 7 days | 0.87 (0.76–0.99) | 0.81 (0.70–0.94) |
| 8 to 30 days | 1.00 (0.84–1.18) | 0.99 (0.82–1.19) |
| Number of contacts within 30 days | ||
| None within 30 days | Reference | Reference |
| >2 | 1.12 (0.93–1.35) | 0.87 (0.70–1.07) |
| 1 or 2 | 0.85 (0.75–0.97) | 0.85 (0.73–0.98) |
| Type of first contact | ||
| None within 30 days | Reference | Reference |
| Clinic visit | 0.90 (0.79–1.02) | 0.85 (0.73–0.98) |
| Telephone contact | 0.87 (0.71–1.05) | 0.85 (0.69–1.06) |
Covariates included age, gender, race/ethnicity, annual household income, graduation from high school, hypertension, diabetes, myocardial infarction, unstable angina, coronary artery bypass graft surgery, percutaneous coronary intervention, atrial fibrillation/flutter, ventricular tachycardia/fibrillation, mitral/aortic valvular disease, depression, dementia, chronic lung disease, chronic liver disease, cancer, permanent pacemaker, implantable cardioverter defibrillator, hospitalization for stroke or transient ischemic attack, hospitalization for heart failure within the prior year, left ventricular ejection fraction category, eGFR, serum potassium, hemoglobin, cardiovascular medication use (ACE inhibitor, ARB, β-blocker, loop diuretic, thiazide diuretic, potassium supplementation, calcium channel blocker, digoxin, nitrates, and hydralazine), and the number of laboratory checks and heart failure medication changes during follow-up.